Alector, Inc. Marketable Securities (Current)
Alector, Inc. (ALEC) had Marketable Securities (Current) of $112.88 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments
us-gaap:MarketableSecuritiesCurrent · last filed 2026-08-06
- 2026-06-30: Marketable Securities, Current $112.88M.
- 2026-03-31: Marketable Securities, Current $129.55M.
- 2025-12-31: Marketable Securities, Current $190.22M.
- 2025-09-30: Marketable Securities, Current $214.60M.
| Period end | Marketable Securities, Current |
|---|---|
| 2026-06-30 | $112.88M 10-Q · filed 2026-08-06 |
| 2026-03-31 | $129.55M 10-Q · filed 2026-05-07 |
| 2025-12-31 | $190.22M 10-Q · filed 2026-08-06 |
| 2025-09-30 | $214.60M 10-Q · filed 2025-11-06 |
| 2025-06-30 | $262.51M 10-Q · filed 2025-08-07 |
| 2025-03-31 | $316.58M 10-Q · filed 2025-05-08 |
| 2024-12-31 | $380.38M 10-K · filed 2026-02-25 |
| 2024-09-30 | $420.04M 10-Q · filed 2024-11-06 |
| 2024-06-30 | $455.79M 10-Q · filed 2024-08-07 |
| 2024-03-31 | $489.53M 10-Q · filed 2024-05-08 |
| 2023-12-31 | $474.31M 10-K · filed 2025-02-26 |
| 2023-09-30 | $486.90M 10-Q · filed 2023-11-07 |
| 2023-06-30 | $498.51M 10-Q · filed 2023-08-03 |
| 2023-03-31 | $473.77M 10-Q · filed 2023-05-04 |
| 2022-12-31 | $558.53M 10-K · filed 2024-02-27 |
| 2022-09-30 | $574.08M 10-Q · filed 2022-11-08 |
| 2022-06-30 | $636.59M 10-Q · filed 2022-08-04 |
| 2022-03-31 | $413.95M 10-Q · filed 2022-05-05 |
| 2021-12-31 | $406.10M 10-K · filed 2023-02-28 |
| 2021-09-30 | $261.32M 10-Q · filed 2021-11-04 |
| 2021-06-30 | $193.86M 10-Q · filed 2021-08-03 |
| 2021-03-31 | $252.04M 10-Q · filed 2021-05-05 |
| 2020-12-31 | $363.34M 10-K · filed 2022-02-24 |
| 2020-09-30 | $376.74M 10-Q · filed 2020-11-10 |
| 2020-06-30 | $411.14M 10-Q · filed 2020-08-11 |
| 2020-03-31 | $387.62M 10-Q · filed 2020-05-13 |
| 2019-12-31 | $263.43M 10-K · filed 2021-02-25 |
| 2019-09-30 | $294.47M 10-Q · filed 2019-11-12 |
| 2019-06-30 | $341.73M 10-Q · filed 2019-08-12 |
| 2019-03-31 | $375.64M 10-Q · filed 2019-05-13 |
| 2018-12-31 | $224.94M 10-K · filed 2020-03-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |